Drug Approval | July 24, 2024
Shilpa Biologicals receives registration approval for Adalimumab from Morocco, MoH
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis
Dexamethasone Tablets USP, 1 mg had annual sales of US$ 1.8 mn in the United States (IQVIA MAT March 24)
SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva
Vision loss due to Glaucoma can be prevented if it is detected and treated early
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions
Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Subscribe To Our Newsletter & Stay Updated
